Authoratory™
 
This website is accredited by Health On the Net Foundation. Click to verify.
Bookmark and Share

4V V Erokhin

 

Summary for 2004 [at-glance overview of V V Erokhin work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author V V Erokhin. According to available data, in 2004 V V Erokhin published at least 4 articles. This work was completed in collaboration with several authors including Gedymin, L E and Lepekha, L N. Several other authors have collaborated with V V Erokhin as well. There is no information about the funding or the grants awarded to support this work.

Analysis of the article abstracts and the titles suggests that V V Erokhin professional interests are focused around "acute pulmonary tuberculosis", "cellular reactions lung" and "patients acute pulmonary". These might also be referred to as "pulmonary tuberculosis", "acute pulmonary" or "reactions lung". Statistical analysis shows that V V Erokhin's writing is likely to contains terms "tuberculosis", "pulmonary", "lung", "leukinferon", "acute" and "therapy".

Unfortunately, there is no affiliation information in V V Erokhin articles. Sadly, no email addresses were found for any of the affiliations.

ENFRESRUAccurate information, makes sense to meInaccurate information, needs improvementmake correctionleave commentask question

Images [images we found on the Internet for V V Erokhin]

    loading...

    Do you know V V Erokhin who matches the profile above? Click the photo and let us know!

Alternative names (0) [other authors with names similar to V V Erokhin]

  • none

Year 2004 Charts [V V Erokhin frequent coauthors and the most common unique vocabulary terms for the selected year]

  • V V Erokhin - Coauthors & Social Network in 2004V V Erokhin - Unique Vocabulary, Keywords and Interests in 2004

Historical Performance Charts [graphical overview of V V Erokhin publication and funding history for the range of years]

  • V V Erokhin - Publications and Funding History in 2004

V V Erokhin Coauthors (6) [all coauthors with the number of joint publications]

 

Other [context-specific ads]

Key Opinion Leader In [V V Erokhin is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

  • no keywords assigned

Keywords (26) [keywords assigned to V V Erokhin articles by PubMed, the leading number and the color conveys importance]

  • 4Humans | 2Tuberculosis, Pulmonary | 2Antitubercular Agents | 2Adult | 2Female | 2Male | 2Russia | 1Pulmonary Fibrosis | 1Cytokines | 1Tuberculosis, Multidrug-Resistant | 1Adjuvants, Immunologic | 1Antigens, CD3 | 1History, 21st Century | 1Lung | 1Academies and Institutes | 1Interferon Type I | 1International Cooperation | 1Drug Combinations | 1Drug Therapy, Combination | 1Middle Aged | 1Neutrophils | 1World Health Organization | 1Acute Disease | 1Biomedical Research | 1Disease Progression | 1Health Services Administration

V V Erokhin Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; V V Erokhin might be a good expert witness on these terms]

  • 9tuberculosis | 6pulmonary | 6lung | 5leukinferon | 4acute | 4therapy | 4tissue | 4patients | 3reactions | 3morphological | 3cellular | 3process | 3drug-resistant | 2immunomodulation | 2effect | 2response | 2used | 2studies | 2combined | 2cases | 2elimination | 2production | 2main | 2exudative | 2specific | 2results | 2reaction | 2necrosis | 2russian | 2elements | 16-month | 1changes
  • 5pulmonary tuberculosis | 4acute pulmonary | 3reactions lung | 2drug-resistant tuberculosis | 2patients acute | 2leukinferon combined | 2therapy acute | 2cellular reactions | 2combined therapy | 2lung drug-resistant | 2tissue cellular | 2main results | 1contents preserved | 1morphological effect | 1inflammation leukinferon | 1effect morphological | 1predominance exudative | 1process specific | 1results prospects | 1without production | 1modalities pathogenetic | 1elimination mycobacterium | 1c57bl mice | 1studied prevalence | 1immunomodulation normalized | 1specific non-specific | 1main | 1involved organs | 1necrosis proliferation | 1factor-alpha healing | 1lung connective | 1preserved extensive
  • 4acute pulmonary tuberculosis | 2cellular reactions lung | 2patients acute pulmonary | 2leukinferon combined therapy | 2reactions lung drug-resistant | 2therapy acute pulmonary | 2combined therapy acute | 2tissue cellular reactions | 2lung drug-resistant tuberculosis | 1generalized nonspecific specific | 1evidence different modalities | 1experiments cba c57bl | 1tissue response decreasing | 1reaction generalized nonspecific | 1organs without production | 1generalization process specific | 12-3 patients acute | 1operated comparison group | 12001-2003 months 2-3 | 1revealed provides evidence | 1leukinferon plays important | 1pulmonary tuberculosis studied | 1alternatively exudative tissue | 1main | 1elements macrophageal response | 1infiltrate resolution decay | 1cases patients operated | 1closure hemo immunomodulation | 1differentiation experimental tuberculosis | 1encapsulation caseous necrosis | 1tuberculosis showed accelerated | 1activities collaborating tuberculosis-combating

Reader's Comments (0) [comments posted by readers of V V Erokhin profile]

no comments yet

Funding (0) [selected NIH grants to V V Erokhin and the award amounts for recent years]

  • award information is not available

V V Erokhin Articles (4) [selected PubMed articles for the year 2004 with the links to a full text at PubMed]

Science Trivia (2) [Interactive math & science trivia questions]